-
The findings of this retrospective study of 825 patients hospitalized with COPD exacerbations indicate that the use of beta blockers in such patients is not harmful and may actually be associated with reduced mortality.
-
Baxter Bioscience has developed a whole-virus, two dose vaccine against avian flu; warning label now on antipsychotics regarding an increased risk of mortality in elderly patients treated for dementia-related psychosis; vitamin D for men with heart disease on horizon? A new oral anticoagulant may soon be available for prevention of thrombotic complications of hip or knee surgery; FDA Actions
-
The ECG shown above was obtained from a 63-year-old man with chest pain. How would you interpret his tracing and accompanying lead II rhythm strip? What is there to worry about?
-
A single injection has been approved for a fifth dose of DTaP and the fourth dose of inactivated polio (IPV) in children 4 to 6 years of age. The combination vaccine is marketed by GlaxoSmithKline as KINRIX.
-
Rosacea patients have increased incidence of small bowel bacterial overgrowth vs controls, and the eradication of this overgrowth leads to almost complete and long-lasting skin lesion regression.
-
-
For years, the debate has continued about returning the results of research to the study participants who made it possible. Would such a process be expensive and unwieldy? Could it cause more harm than good, when participants receive bad news?
-
When is the dual role of physician/investigator a conflict of interest? This is the question IRBs might consider in the aftermath of clinical trial participant Dan Markingson's suicide.
-
-
When the answer to the question of "Could there be incidental findings from this study?" is "Yes," experts agree that the protocol should include an incidental findings management plan.